Molecule Information
General Information of the Molecule (ID: Mol01068)
Name |
Ribonuclease PH (RPH)
,Listeria monocytogenes
|
||||
---|---|---|---|---|---|
Synonyms |
RNase PH; tRNA nucleotidyltransferase; LMOf2365_1247
Click to Show/Hide
|
||||
Molecule Type |
Protein
|
||||
Gene Name |
rph
|
||||
Sequence |
MRVDGRESNALRNIEVTPDYLMHPEGSVLIASGNTKVICSASVETKVPPFMRGEGRGWIS
AEYSMLPRATNTRNIRESSKGKVTGRTMEIQRLIGRALRAVVDLDALGERTIWLDCDVIQ ADGGTRTASITGAFIAMVMAIAKLDEAVPFAKFPVKDFLAATSVGVLEEGGTVLDLNYVE DSAAQVDMNIIMTGSGAFVELQGTGEEATFSETELAELIALGKKGISELIEIQKETLGDK VTARIKGE Click to Show/Hide
|
||||
Function |
Phosphorolytic 3'-5' exoribonuclease that plays an important role in tRNA 3'-end maturation. Removes nucleotide residues following the 3'-CCA terminus of tRNAs; can also add nucleotides to the ends of RNA molecules by using nucleoside diphosphates as substrates, but this may not be physiologically important. Probably plays a role in initiation of 16S rRNA degradation (leading to ribosome degradation) during starvation.
Click to Show/Hide
|
||||
Uniprot ID | |||||
Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
DISM: Drug Inactivation by Structure Modification
Drug Resistance Data Categorized by Drug
Approved Drug(s)
2 drug(s) in total
Rifampin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Drug Inactivation by Structure Modification (DISM) | ||||
Disease Class: HIV-infected patients with tuberculosis | [1], [2], [3] | |||
Resistant Disease | HIV-infected patients with tuberculosis [ICD-11: 1C60.0] | |||
Resistant Drug | Rifampin | |||
Molecule Alteration | Expression | Up-regulation |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli TOP10 | 83333 | ||
Bacillus cereus RPH-Bc | 1396 | |||
Escherichia coli Rosetta(DE3) pLysS | 866768 | |||
L. monocytogenes | 1639 | |||
Experiment for Molecule Alteration |
Whole genome sequence assay | |||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | RIF phosphotransferase (rph) led to the identification of a new resistance gene and associated enzyme responsible for inactivating rifamycin antibiotics by phosphorylation. |
Rifaximin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Drug Inactivation by Structure Modification (DISM) | ||||
Disease Class: MycoBacterial infection | [1], [2], [3] | |||
Resistant Disease | MycoBacterial infection [ICD-11: 1B2Z.1] | |||
Resistant Drug | Rifaximin | |||
Molecule Alteration | Expression | Up-regulation |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli TOP10 | 83333 | ||
Bacillus cereus RPH-Bc | 1396 | |||
Escherichia coli Rosetta(DE3) pLysS | 866768 | |||
L. monocytogenes | 1639 | |||
Experiment for Molecule Alteration |
Whole genome sequence assay | |||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | RIF phosphotransferase (rph) led to the identification of a new resistance gene and associated enzyme responsible for inactivating rifamycin antibiotics by phosphorylation. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.